Northwest Biotherapeutics | NWBO - Market Capitalization


Northwest Biotherapeutics reported $278.7M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 204M 164M Jun/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Celldex Therapeutics USD 1.72B 367M Sep/2025
Eisai JPY 1.43T 119.2B Feb/2026
Infinity Pharmaceuticals USD 19M 5M Jun/2023
Merck USD 300.37B 39.11B Feb/2026
Northwest Biotherapeutics USD 1.02B 403M Sep/2023
Pfizer USD 152.89B 11.32B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025